
--- Page 1 ---
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION
DECISION SUMMARY
ASSAY ONLY TEMPLATE
A. 510(k) Number:
k072409
B. Purpose for Submission:
Clearance of new device
C. Measurand:
Albumin
Creatinine
D. Type of Test:
Albumin – Quantitative immunochemical assay
Creatinine – Quantitative enzymatic assay
E. Applicant:
AXIS-SHIELD POC AS
F. Proprietary and Established Names:
Afinion™ ACR and Afinion™ ACR Control
G. Regulatory Information:
Product Classification Regulation Section Panel
Code
JIR Class I subject 862.1645 - Urinary protein or albumin 75
to 862.9 (c)(5) (nonquantitative) test system.
JFY Class II 862.1225 Creatinine test system. 75
JJY Class I 862.1660 Quality control material (assayed and 75
reserved unassayed).
1 of 13

[Table 1 on page 1]
	Product		Classification	Regulation Section	Panel
	Code				
JIR			Class I subject
to 862.9 (c)(5)	862.1645 - Urinary protein or albumin
(nonquantitative) test system.	75
JFY			Class II	862.1225 Creatinine test system.	75
JJY			Class I
reserved	862.1660 Quality control material (assayed and
unassayed).	75

--- Page 2 ---
H. Intended Use:
1. Intended use(s):
Afinion™ ACR is an in vitro diagnostic test for quantitative determination of
albumin, creatinine and albumin/creatinine ratio (ACR) in human urine. The
measurement of urine albumin, creatinine and albumin/creatinine ratio aids in the
early diagnosis of nephropathy.
Afinion™ ACR Control is a assayed in vitro diagnostic quality control material
used to confirm that the Afinion™ ACR and the Afinion™ AS100 Analyzer
System is working properly and provides reliable results.
2. Indication(s) for use:
Afinion™ ACR is an in vitro diagnostic test for quantitative determination of
albumin, creatinine and albumin/creatinine ratio (ACR) in human urine. The
measure of urine albumin aids in the early diagnosis of nephropathy.
Afinion™ ACR Control is a assayed in vitro diagnostic quality control material
used to confirm that the Afinion™ ACR and the Afinion™ AS100 Analyzer
System is working properly and provides reliable results.
3. Special conditions for use statement(s):
For prescription use only
4. Special instrument requirements:
Afinion™ ACR is used with the Afinion™ AS100 Analyzer
I. Device Description:
The main components of the Afinion™ ACR Test Cartridge are the sampling device
and the reaction container. The Test Cartridge has a handle, a barcode label with lot
specific information and an area for sample ID.
Material provided:15 Afinion™ ACR Test Cartridges packaged separately in foil
pouches with a desiccant bag, 1 Package Insert
The Afinion™ ACR Control kit contains liquid preparations of albumin and
creatinine in citrate buffer. The Afinion™ ACR Controls have been designed for use
with the Afinion™ AS100 Analyzer and the Afinion™ ACR test.
Control kit contents: 1 Afinion™ ACR Control C I: Citrate buffer with albumin and
creatinine (1x1.0 mL), 1 Afinion™ ACR Control C II: Citrate buffer with albumin
and creatinine (1x1.0 mL), 1 Package Insert
2 of 13

--- Page 3 ---
J. Substantial Equivalence Information:
DCA 2000Â® Microalbumin/Creatinine Assay k963142
Predicate Item Similarities Differences
K963142 - DCA
2000Â® Analytes
Albumin, creatinine and ACR N/A
Microalbumin/Creatinine measured
Assay
K963142 - DCA
In vitro diagnostic test for
2000Â® Intended
quantitative determination of N/A
Microalbumin/Creatinine use
albumin, creatinine and ACR
Assay
K963142 - DCA
2000Â® Sample
Human urine N/A
Microalbumin/Creatinine material
Assay
K963142 - DCA
2000Â® Type of
Point of Care testing N/A
Microalbumin/Creatinine test
Assay
Afinion™ ACR: Immunometric
membrane flow-through
principle where the color
intensity of the membrane is
measured by reflection.
K963142 - DCA
Assay
2000Â®
principle N/A DCA® 2000
Microalbumin/Creatinine
for albumin Microalbumin/Creatinine assay:
Assay
A specific antibody binds with
albumin in the presence of
polyethylene glycol. The
albumin antibody complexes are
measured as absorbance.
Afinion™ ACR: An enzymatic
colorimetric test where the
creatinine concentration is
measured by transmission.
K963142 - DCA Assay
2000Â® principle
N/A DCA® 2000
Microalbumin/Creatinine for
Microalbumin/Creatinine assay:
Assay creatinine
Benedict/Behre chemistry (non
enzymatic) and the creatinine
concentration is quantified by
absorbance.
Afinion™ ACR: Albumin 5.0-
200.0 mg/L
K963142 - DCA
Measuring
2000Â®
range N/A DCA® 2000
Microalbumin/Creatinine
albumin Microalbumin/Creatinine assay:
Assay
5.0-300.0 mg/L
3 of 13

[Table 1 on page 3]
Predicate	Item	Similarities	Differences
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Analytes
measured	Albumin, creatinine and ACR	N/A
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Intended
use	In vitro diagnostic test for
quantitative determination of
albumin, creatinine and ACR	N/A
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Sample
material	Human urine	N/A
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Type of
test	Point of Care testing	N/A
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Assay
principle
for albumin	N/A	Afinion™ ACR: Immunometric
membrane flow-through
principle where the color
intensity of the membrane is
measured by reflection.
DCA® 2000
Microalbumin/Creatinine assay:
A specific antibody binds with
albumin in the presence of
polyethylene glycol. The
albumin antibody complexes are
measured as absorbance.
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Assay
principle
for
creatinine	N/A	Afinion™ ACR: An enzymatic
colorimetric test where the
creatinine concentration is
measured by transmission.
DCA® 2000
Microalbumin/Creatinine assay:
Benedict/Behre chemistry (non
enzymatic) and the creatinine
concentration is quantified by
absorbance.
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Measuring
range
albumin	N/A	Afinion™ ACR: Albumin 5.0-
200.0 mg/L
DCA® 2000
Microalbumin/Creatinine assay:
5.0-300.0 mg/L

--- Page 4 ---
Predicate Item Similarities Differences
Afinion™ ACR: 16.4-339.9
K963142 - DCA mg/dL
Measuring
2000Â®
range N/A
Microalbumin/Creatinine DCA® 2000
creatinine
Assay Microalbumin/Creatinine assay:
15-500 mg/dL
K963142 - DCA Afinion™ ACR: 1.0-1250.0
2000Â® Measuring mg/g
N/A
Microalbumin/Creatinine range ACR
Assay DCA® 2000: 1-2000 mg/g
Afinion™ ACR: 3.5 µL
K963142 - DCA
2000Â® Sample
N/A DCA® 2000
Microalbumin/Creatinine volume
Microalbumin/Creatinine assay:
Assay
40 µL
K963142 - DCA
2000Â® Test
Ready to use N/A
Microalbumin/Creatinine cartridges
Assay
Afinion™ ACR: ready to use
K963142 - DCA
2000Â® Control
2 control levels DCA® 2000
Microalbumin/Creatinine material
Microalbumin/Creatinine assay:
Assay
lyophilized
Storage
K963142 - DCA temperature
2000Â® for test
2-8 °C N/A
Microalbumin/Creatinine cartridges
Assay and control
material
Afinion™ ACR: albumin 3-8
%CV, creatinine 3-8 %CV.
K963142 - DCA Total
2000Â® precision
DCA® 2000 N/A
Microalbumin/Creatinine (external
Microalbumin/Creatinine assay:
Assay study)
albumin 2.7-6.6 %CV, creatinine
2.8-3.6 %CV
Afinion™ ACR: 5 min 35 sec
K963142 - DCA
2000Â®
Assay time N/A DCA® 2000
Microalbumin/Creatinine
Microalbumin/Creatinine assay:
Assay
7 minutes
Afinion™ ACR: Built in
K963142 - DCA
2000Â® DCA® 2000
Calibration N/A
Microalbumin/Creatinine Microalbumin/Creatinine assay:
Assay Calibration card for test and
controls
4 of 13

[Table 1 on page 4]
Predicate	Item	Similarities	Differences
			
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Measuring
range
creatinine	N/A	Afinion™ ACR: 16.4-339.9
mg/dL
DCA® 2000
Microalbumin/Creatinine assay:
15-500 mg/dL
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Measuring
range ACR	N/A	Afinion™ ACR: 1.0-1250.0
mg/g
DCA® 2000: 1-2000 mg/g
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Sample
volume	N/A	Afinion™ ACR: 3.5 µL
DCA® 2000
Microalbumin/Creatinine assay:
40 µL
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Test
cartridges	Ready to use	N/A
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Control
material	2 control levels	Afinion™ ACR: ready to use
DCA® 2000
Microalbumin/Creatinine assay:
lyophilized
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Storage
temperature
for test
cartridges
and control
material	2-8 °C	N/A
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Total
precision
(external
study)	Afinion™ ACR: albumin 3-8
%CV, creatinine 3-8 %CV.
DCA® 2000
Microalbumin/Creatinine assay:
albumin 2.7-6.6 %CV, creatinine
2.8-3.6 %CV	N/A
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Assay time	N/A	Afinion™ ACR: 5 min 35 sec
DCA® 2000
Microalbumin/Creatinine assay:
7 minutes
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Calibration	N/A	Afinion™ ACR: Built in
DCA® 2000
Microalbumin/Creatinine assay:
Calibration card for test and
controls

--- Page 5 ---
Predicate Item Similarities Differences
Afinion™ ACR: 15 tests
K963142 - DCA
2000Â®
Kit size Separately packed cartridges DCA® 2000
Microalbumin/Creatinine
Microalbumin/Creatinine assay:
Assay
10 tests
K. Standard/Guidance Document Referenced (if applicable):
STANDARDS
Title and Reference Number
Stability Testing of In Vitro Diagnostic Reagents (CEN-13640)
Evaluation of Precision Performance of Quantitative Measurement Methods; Approved
Guideline-Second Edition (EP5-A2)
L. Test Principle:
Afinion™ ACR is a fully automated assay for determination of albumin, creatinine
and ACR in human urine. Albumin is quantified using a solid phase
immunochemical assay. In the Afinion™ ACR Test Cartridge the sample is
automatically diluted and aspirated through a membrane coated with anti-albumin
antibodies, which concentrates and immobilizes the albumin from the sample. A
gold-antibody conjugate then binds to the immobilized albumin resulting in a red-
brown colored membrane. Excess gold-antibody conjugate is removed in a washing
step. The Afinion™ AS100 Analyzer measures the color intensity of the membrane,
which is proportional to the amount of albumin in the sample.
Creatinine is quantified using an enzymatic colorimetric test that involves four
enzymatic steps. The test requires incubation with two distinct enzyme solutions. A
colored end product is measured in one of the cartridge wells.
M. Performance Characteristics (if/when applicable):
1. Analytical performance:
a. Precision/Reproducibility:
A 20 day study was performed with the Afinion™ ACR assay using the
Afinion™ AS100 Analyzer to estimate the within-day, within-run, between-
day and total precision according to Clinical and Laboratory Standards
Institute (CLSI) guideline EP5-A2.
Within-day precision was run with 20 replicates in one day. For within-run,
between day and total precision, the testing was performed over 20 operating
days. Each sample was measured in duplicate in two daily runs with a
minimum of two hours between the two runs. Three urine samples were
5 of 13

[Table 1 on page 5]
Predicate	Item	Similarities	Differences
K963142 - DCA
2000Â®
Microalbumin/Creatinine
Assay	Kit size	Separately packed cartridges	Afinion™ ACR: 15 tests
DCA® 2000
Microalbumin/Creatinine assay:
10 tests

[Table 2 on page 5]
STANDARDS
Title and Reference Number
Stability Testing of In Vitro Diagnostic Reagents (CEN-13640)
Evaluation of Precision Performance of Quantitative Measurement Methods; Approved
Guideline-Second Edition (EP5-A2)

--- Page 6 ---
collected and stored frozen until use. No samples were spiked. The samples
were analyzed in random order for each run.
Within day imprecision results (20 replicates in 1 day) for albumin, creatinine
and ACR.
Sample S 1 S 2 S 3
Analyte mean CV % mean CV % mean CV %
Albumin, mg/L 176.7 3.9 55.7 4.6 13.0 3.5
Creatinine, mg/dL 52.7 3.2 163.7 3.8 351.4 3.3
ACR, mg/g 335.8 5.2 34.1 4.2 3.7 4.0
Within run imprecision results for albumin, creatinine and ACR, 20 days
testing of 3 urine samples.
Sample S 1 S 2 S 3
Within run mean CV % mean CV % mean CV %
Albumin, mg/L 174.9 4.3 55.3 3.3 12.6 4.4
Creatinine, mg/dL 51.4 3.4 162.3 2.1 348.1 2.7
ACR, mg/g 340.6 5.3 34.1 3.7 3.6 5.0
Between day imprecision results for Albumin, Creatinine and ACR values
after 20 days testing of 3 urine samples.
Sample S 1 S 2 S 3
Between day mean CV % mean CV % mean CV %
Albumin, mg/L 174.9 2.0 55.3 0.0 12.6 1.2
Creatinine, mg/dL 51.4 0.0 162.3 0.0 348.1 0.6
ACR, mg/g 340.6 2.8 34.1 0.7 3.6 0.0
Total imprecision of Albumin, Creatinine and ACR values after 20 days
testing of 3 urine samples.
Sample S 1 S 2 S 3
Total mean CV % mean CV % mean CV %
Albumin, mg/L 174.9 5.0 55.3 4.8 12.6 5.5
Creatinine, mg/dL 51.4 3.8 162.3 2.8 348.1 3.0
ACR, mg/g 340.6 6.0 34.1 4.6 3.6 6.0
6 of 13

[Table 1 on page 6]
Sample	S 1		S 2		S 3	
Analyte	mean	CV %	mean	CV %	mean	CV %
Albumin, mg/L	176.7	3.9	55.7	4.6	13.0	3.5
Creatinine, mg/dL	52.7	3.2	163.7	3.8	351.4	3.3
ACR, mg/g	335.8	5.2	34.1	4.2	3.7	4.0

[Table 2 on page 6]
Sample	S 1		S 2		S 3	
Within run	mean	CV %	mean	CV %	mean	CV %
Albumin, mg/L	174.9	4.3	55.3	3.3	12.6	4.4
Creatinine, mg/dL	51.4	3.4	162.3	2.1	348.1	2.7
ACR, mg/g	340.6	5.3	34.1	3.7	3.6	5.0

[Table 3 on page 6]
Sample	S 1		S 2		S 3	
Between day	mean	CV %	mean	CV %	mean	CV %
Albumin, mg/L	174.9	2.0	55.3	0.0	12.6	1.2
Creatinine, mg/dL	51.4	0.0	162.3	0.0	348.1	0.6
ACR, mg/g	340.6	2.8	34.1	0.7	3.6	0.0

[Table 4 on page 6]
Sample	S 1		S 2		S 3	
Total	mean	CV %	mean	CV %	mean	CV %
Albumin, mg/L	174.9	5.0	55.3	4.8	12.6	5.5
Creatinine, mg/dL	51.4	3.8	162.3	2.8	348.1	3.0
ACR, mg/g	340.6	6.0	34.1	4.6	3.6	6.0

--- Page 7 ---
b. Linearity/assay reportable range:
Afinion™ ACR reportable range is supported by linearity and detection
limit below:
Albumin Creatinine ACR
Reportable range 5.0-200.0 mg/L 16.4-339.9 mg/dL 1.0-1250.0 mg/g
If the patient’s albumin or creatinine value is outside the reportable range,
no ACR test result will be reported
Procedure:
Two dilution series, one for albumin, AL1-AL10 and one for creatinine, CL1-
CL10, were prepared by inter-mixing the high and low concentration of
albumin and creatinine in urine samples as described in the table below:
Sample name Sample Low Sample High
(µL) = V (µL) = V
1 2
AL1 or CL1 0 300
AL2 or CL2 60 240
AL3 or CL3 90 210
AL4 or CL4 120 180
AL5 or CL5 150 150
AL6 or CL6 180 120
AL7 or CL7 210 90
AL8 or CL8 240 60
AL9 or CL9 270 30
AL10 or CL110 300 0
The following linear regression results were obtained:
Analyte r² slope y-intercept
Albumin 1.00 1.01 ± 0.02 -4.1 ± 1.9 mg/L
Creatinine 1.00 0.99 ± 0.01 0.5 ± 2.1 mg/dL
Theoretical and measured albumin values.
Sample Theoretical Measured CV % % Recovery
albumin (mg/L) Mean albumin
(mg/L)
AL1 201.8 201.8 5.3 N/A
AL2 162.2 159.0 3.9 98
AL3 142.5 148.4 3.0 104
AL4 122.7 124.3 4.0 101
7 of 13

[Table 1 on page 7]
Sample name	Sample Low
(µL) = V
1	Sample High
(µL) = V
2
AL1 or CL1	0	300
AL2 or CL2	60	240
AL3 or CL3	90	210
AL4 or CL4	120	180
AL5 or CL5	150	150
AL6 or CL6	180	120
AL7 or CL7	210	90
AL8 or CL8	240	60
AL9 or CL9	270	30
AL10 or CL110	300	0

[Table 2 on page 7]
Analyte	r²	slope	y-intercept
Albumin	1.00	1.01 ± 0.02	-4.1 ± 1.9 mg/L
Creatinine	1.00	0.99 ± 0.01	0.5 ± 2.1 mg/dL

[Table 3 on page 7]
Sample	Theoretical
albumin (mg/L)	Measured
Mean albumin
(mg/L)	CV %	% Recovery
AL1	201.8	201.8	5.3	N/A
AL2	162.2	159.0	3.9	98
AL3	142.5	148.4	3.0	104
AL4	122.7	124.3	4.0	101

--- Page 8 ---
Sample Theoretical Measured CV % % Recovery
albumin (mg/L) Mean albumin
(mg/L)
AL5 102.9 106.8 4.7 104
AL6 83.1 89.7 4.6 108
AL7 63.3 67.3 4.6 106
AL8 43.6 48.3 2.7 111
AL9 23.8 27.5 4.4 116
AL10 4.0 4.0 4.3 N/A
Theoretical and measured creatinine values
Measured Theoretical CV % % Recovery
Sample
Mean creatinine creatinine (mg/dL)
(mg/dL)
CL1 343.7 343.7 2.2 N/A
CL 2 275.3 277.2 2.0 99
CL3 250.8* 244.0 2.0 103
CL 4 217.4 210.7 3.8 103
CL5 174.2 177.5 4.4 98
CL 6 145.8 144.3 1.5 101
CL7 109.5 111.0 3.5 99
CL 8 77.4 77.8 1.8 99
CL9 44.4 44.5 4.1 100
CL10 11.3 11.3 8.2 N/A
The albumin and creatinine assays show acceptable linearity over the
measuring ranges.
c. Traceability, Stability, Expected values (controls, calibrators, or methods):
Test specific calibration data are established for each lot of test cartridges and
then stored in the barcode label. When the Test Cartridge enters the Analyzer,
the integrated camera reads the barcode. The calibration data for the actual lot
are transferred to the instrument and used for calculating results. Calibration
by the operator is thus not required.
The albumin standards are traceable to ERM®-DA 470 and the creatinine
standards are traceable to SRM 914a. Controls and calibrators are prepared
gravimetrically. Values are assigned using analysis of multiple replicates on
multiple analyzers and multiple lots.
8 of 13

[Table 1 on page 8]
Sample	Theoretical
albumin (mg/L)	Measured
Mean albumin
(mg/L)	CV %	% Recovery
AL5	102.9	106.8	4.7	104
AL6	83.1	89.7	4.6	108
AL7	63.3	67.3	4.6	106
AL8	43.6	48.3	2.7	111
AL9	23.8	27.5	4.4	116
AL10	4.0	4.0	4.3	N/A

[Table 2 on page 8]
Sample	Measured
Mean creatinine
(mg/dL)	Theoretical
creatinine (mg/dL)	CV %	% Recovery
CL1	343.7	343.7	2.2	N/A
CL 2	275.3	277.2	2.0	99
CL3	250.8*	244.0	2.0	103
CL 4	217.4	210.7	3.8	103
CL5	174.2	177.5	4.4	98
CL 6	145.8	144.3	1.5	101
CL7	109.5	111.0	3.5	99
CL 8	77.4	77.8	1.8	99
CL9	44.4	44.5	4.1	100
CL10	11.3	11.3	8.2	N/A

--- Page 9 ---
Afinion™ ACR Control C I and C II were used when performing the external
precision study for Afinion™ ACR Control. The controls C I and C II
represent two different levels of albumin and creatinine according to table
below and contains liquid preparations of albumin and creatinine in citrate
buffer.
Target values for Afinion™ ACR Control C I and C II are assigned within
the following ranges.
Specification Target value Target value Target value
Albumin Creatinine ACR
(mg/L) (mg/dL) (mg/g)
Afinion™ ACR 9-15 79.2-101.8 8.8-18.9
Control C I
Afinion™ ACR 65-95 203.6-248.8 26.1-46.7
Control C II
Stability studies are conducted to determine the stability of Afinion™
ACR Control at the following conditions:
1. Real time storage at 5 ± 3 °C.
2. Open bottle at recommended storage at 5 ± 3 °C.
3. Continuous open bottle at room temperature.
4. Controlled room temperature storage..
5. Transport simulation (Warehouse/Shipping, W/S) of kits stressed at 37
± 2 °C for 3 days followed by storage at 5 ± 3 °C.
6. Transport simulation (Freeze/Thaw, F/T) of kits stressed for 3
freeze/thaw cycles followed by storage at 5 ± 3 °C.
Study protocols and acceptance criteria were described and found to be
acceptable.
d. Detection limit:
The applicant determined the Limits of Detection (LoD) and the Limits of
Quantitation (LoQ) for Albumin and Creatinine in the ACR assay according
to CLSI protocol EP17-A.
The LoD is 0.5 mg/L for Albumin and 1.9 mg/dL for Creatinine
The LoQ is 2.5 mg/L for Albumin and 5.0 mg/dL for Creatinine
9 of 13

[Table 1 on page 9]
Specification	Target value
Albumin
(mg/L)	Target value
Creatinine
(mg/dL)	Target value
ACR
(mg/g)
Afinion™ ACR
Control C I	9-15	79.2-101.8	8.8-18.9
Afinion™ ACR
Control C II	65-95	203.6-248.8	26.1-46.7

--- Page 10 ---
e. Analytical specificity:
No cross-reaction was found when the albumin monoclonal antibodies were
tested on human hemoglobin, IgG, IgA, beta-2 microglobulin, myoglobin and
bovine serum albumin. (Note: See below. Interference from blood was
observed with this device)
Interference
No significant interference was observed for both albumin and creatinine up
to the following concentrations in urine:
Acetoacetate 0.84 mg/mL 7.8 mmol/L
Acetone 800 mg/L 13.8 mmol/L
Ascorbic acid 3000 mg/L 16.7 mmol/L
Bilirubin 3.5 mg/dL 0.06 mmol/L
Creatine 0.52 mg/mL 4.0 mmol/L
Glucose 45 mg/mL 250 mmol/L
beta-hydroxybutyric acid 5.9 mg/mL 46.8 mmol/L
IgG 20 mg/L
Beta-2 microglobulin 20 mg/L
Myoglobin 20 mg/L
Urea 30 mg/mL 500 mmol/L
Over the counter and prescription drugs:
Acetaminophen 0.2 mg/mL 1.5 mmol/L
Acetaminophen-glucuronide 10.5 mg/mL 30.0 mmol/L
Glyburide 14.8 µg/mL 30 µmol/L
Ibuprofen 2.0 mg/mL 10 mmol/L
Metformin 4.0 mg/mL 24 mmol/L
Blood interference
Interference from blood may falsely elevate assay results when urine stick
results are greater than or equal to 25 erythrocytes/uL.
No “Hook effect” was observed at albumin concentrations up to 5000 mg/L.
f. Assay cut-off:
Not Applicable
10 of 13

--- Page 11 ---
2. Comparison studies:
a. Method comparison with predicate device:
External study
A method comparison study, comprising 169 urine samples was performed at
four physicians’ office laboratories. Analyte concentrations were evenly
distributed with albumin ranging from 5.0 to 200.0 mg/dL and for creatinine
from 17.0 and 339.4. Urine samples were collected from the donors and
analyzed with Afinion™ ACR and another point-of-care method at the four
study sites. The operators were either nurses or medical assistants.
The correlation data (Passing-Bablok analysis) are summarized below from
the method comparison study - Afinion™ ACR (y) vs. another point-of care
method (x) at four sites. (Linear regression analysis data, N= number of
samples, r=correlation coefficient).
Analyte N Regression line r
Albumin 169 Y=1.10x + 1.4 0.99
Creatinine 169 Y=0.93x + 2.3 0.99
ACR 169 Y=1.16x + 1.0 0.99
Internal study performed at Axis shield PoC
Similarly another method comparison study comprised of 95 urine samples,
with concentrations evenly distributed for albumin ranging from 5.0 to 199.6
mg/dL and creatinine from 17.4 and 332.2. were analyzed with Afinion™
ACR and another point-of-care method. The correlation data (Passing-Bablok
analysis) are summarized here.
Analyte N Regression line r
Albumin 91 Y=0.92x + 2.1 0.99
Creatinin 95 Y=1.00x – 3.2 0.99
e
ACR 91 Y=1.01x + 0.7 0.99
b. Matrix comparison:
Not Applicable
3. Clinical studies:
a. Clinical Sensitivity:
Not Applicable
11 of 13

[Table 1 on page 11]
Analyte	N	Regression line	r
Albumin	169	Y=1.10x + 1.4	0.99
Creatinine	169	Y=0.93x + 2.3	0.99
ACR	169	Y=1.16x + 1.0	0.99

[Table 2 on page 11]
Analyte	N	Regression line	r
Albumin	91	Y=0.92x + 2.1	0.99
Creatinin
e	95	Y=1.00x – 3.2	0.99
ACR	91	Y=1.01x + 0.7	0.99

--- Page 12 ---
b. Clinical specificity:
Not Applicable
c. Other clinical supportive data (when a. and b. are not applicable):
Not Applicable
4. Clinical cut-off:
Not Applicable
5. Expected values/Reference range:
Reportable range of the Afinion™ ACR assay for Albumin: 5.0-200 mg/L.
Albumin values and medical decision points:
* Normal: < 20 mg/L
* Microalbuminuria: 20-200 mg/L
* Clinical albuminuria: > 200 mg/L
Ref: Janssen, W. M. T et al. Clin Chem Lab Med; 38 (11): 1107-1110; 2000.
Torffvit, O. Diabetolognytt; No 1-2; 2002.
Reportable range of the Afinion™ ACR assay for Creatinine is 16.4-339.9 mg/dL
The normal range for urine creatinine: 34-147 mg/dL
Ref: Foss OP. Fysiologi Patofysiologi Klinsk Kjem. Noen momenter for
fysiokjemikere, 2nd ed.Ulleval sykehus, Oslo, 1981; 99/
Reportable range of the Afinion™ ACR assay for Albumin Creatinine Ratio
(ACR): 1.0-1250 mg/g.
ACR values and medical decision points:
* Normal: < 30 mg/g
* Microalbuminuria: 30-300 mg/g
* Clinical albuminuria: > 300 mg/g
Ref: American Diabetes Association. Diabetes care, Vol. 25, Suppl.1, January
2002.
N. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.
12 of 13

--- Page 13 ---
O. Conclusion:
The submitted information in this premarket notification is complete and supports a
substantial equivalence decision.
13 of 13